Clinical Trials Using PARP/Tankyrase Inhibitor 2X-121
Review the clinical trials studying parp/tankyrase inhibitor 2x-121 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-2 of
2
- Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian CancerStatus: ActiveLocation: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
- Status: Temporarily Closed to AccrualLocation: 2 locations